Friday, October 9, 2020

Very Brief Blog: Startup with Tiny Handheld Raises $60M, Gets FDA EUA, Raises Extra $10M from NIH RADx

Visby Medical, a team I was able to help in their early planning phases for commercialization a couple years ago, has had a run of good news this year.  Their product is a tiny molecular testing POCT handheld device. See my September note here.

In April, early in the COVID epidemic, the Stanford spinout raised $70M.   In September, they got an FDA EUA for their highly innovative device.   In October, they announced an additional $10M from the NIH RADx tech investment fund.

See latest announcement here.